Cadila Healthcare has completed the acquisition of two ANDAs from Teva through its subsidiary Zydus Worldwide. The acquisition was contingent on Teva's acquisition of Allergan's generic business, which has now closed with FTC approval. Tata Chemicals reported a 32.3% rise in Q1 net profit to Rs 279.65 crore compared to Rs 211.31 crore in the same quarter last year, aided by better performance and margins in the Indian business. Asian shares rose on Monday after a stronger-than-expected July US jobs report boosted confidence in the strength of the US economy and heightened expectations of a US interest rate hike this year.

1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
PharmagiantCadilaHealthcareLtdonFridaysaidthatithascompletedtheacquisitionoftwoANDAsfromTevathroughits100percentsubsidiary,
Zydus Worldwide DMCC. On June 20, 2016, the company had announced the acquisition of two ANDAs from Teva that were being divested by
Teva as a pre-condition to its acquisition of Allergan's generic business. The acquisition of these ANDAs was contingent on the closing of the Teva-
Allergan Generics transaction and approval by the US Federal Trade Commission. Ina filing to the Bombay Stock Exchange, Cadila Healthcare said,
“ThetransactionhasnowbeencompletedandtheseANDAshavebeenacquiredbyits100percentsubsidiary,ZydusWorldwideDMCC.”
Technical Outlook: On daily chart, stock has formed long leg of lower shadow candlestick which is a continuation pattern of current
trend.Moreover,stockhasbeentradingaboveits21daymovingaveragewhichisplacedat364.60levelwhichshowsthatneartermtrend
is up. A momentum indicator RSI reading is at 62.30 level with positive crossover, which point out for positive breath in the stock. So for
tradingperspective,onecouldBuyinrangeof374-376forTargetof384withSLof370.20
CADILAHC
TATACHEM
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
08th Aug 2016
Buy in range of 474-476 for Target of 486 with SL of 469.30
Buy in range of 374-376 for Target of 384 with SL of 370.20
Tata Chemicals Ltd has reported 32.3 per cent jump in its consolidated net profit at Rs 279.65 crore for the first quarter ended June 30, 2016. The
company had registered a net profit of Rs 211.31 crore in the corresponding quarter last fiscal, the company said in a filing to the Bombay Stock
Exchange. Commenting on the development, R. Mukundan, Managing Director, Tata Chemicals Ltd, said, “ The quarter under review witnessed
strong performance of the Chemicals and Consumer business in India. Our continued focus on improving operational performance has ensured
betterperformanceacrossgeographies,alongwithstrongperformanceoftheIndianchemicalsbusiness.ThistookthenetprofittoRs.206Crona
consolidated basis. However, we remain watchful of the volatility in the markets. Stand - alone net profit was at Rs. 203 Cr , up 21 per cent due to
betterperformanceandmarginsintheIndianbusiness.”
Technical Outlook: On daily chart, stock has formed strong bull candlestick with above average volume, which shows that accentuated
buying activity during last trading session. Moreover, stock has taken support of its 21 day moving average and gave good bounce back,
which shows that near term trend is up. A momentum indicator RSI reading is at 63.55 level with positive crossover, which point out for
positivebreathinthestock.Sofortradingperspective,onecouldBuyinrangeof474-476forTargetof486withSLof469.30.
Asian shares rose on Monday and the dollar stood tall after a stronger-than-expected July jobs report lifted confidence in the strength of
the US economy - heightening expectations that the US Federal Reserve could hike interest rates this year. MSCI's broadest index of Asia-
Pacific shares outside Japan rose 0.2 percent in early trading, after gaining 0.7 percent last week. US shares logged solid gains on Friday,
with both the S&P 500 and the Nasdaq Composite closing at record highs. Japan's Nikkei stock index, which skidded 1.9 percent last week
in the face of a strengthening yen, was 1.6 percent higher in early trade. The SGX Nifty suggests a gap up opening for our markets as it is
tradingat8754,Upby51points.
USstocksnotchedtheirbestdayinamonthonFriday,withtheS&P500andNasdaqclosingatrecordhighsafterasecondstraightmonthofrobust
labormarketdataboostedoptimismthateconomicgrowthisaccelerating.TheUSLaborDepartmentreportshowedthatnonfarmpayrollsroseby
255,000 in July,faroutpacing expectations for again of 180,000. While the unemployment rate remainedunchangedat 4.9 percent, it held below
the 5 percent mark associated with full employment. The Dow Jones industrial average rose 191.21 points, or 1.04 percent, to 18,543.26, the S&P
500gained18.57points,or0.86percent,to2,182.82 andtheNasdaqCompositeadded54.87 points,or1.06percent,to5,221.12.

2. SEBI Certified – Research Analyst www.choiceindia.comSEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
08th Aug 2016
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
AdvaniHotels&Resorts(India)Limited;Dividend-Re0.20PerShare
NCCLimited;Dividend-Re0.60/-PerShare
SintexIndustriesLimited;Dividend-Re0.70/-PerShare/Right26:151
HexawareTechnologiesLimited;Dividend-Re1/-PerShare
TataGlobalBeveragesLimited;AnnualGeneralMeeting/DividendRs2.25PerShare
AutomotiveAxlesLimited;Dividend-Rs5.50/-PerShare
DhanukaAgritechLimited;AnnualGeneralMeeting
Result Calendar:
20MICRONS, ADINATHBI, ANJANIFIN, ARFIN, ASHIKACR, ASIANHOTNR, BANSWRAS, BAYERCROP, BENTCOM,
BLACKROSE, BRITANNIA, CAREERP, CINERAD, COLPAL, CRANEINFRA, CROWNTOURS, DARJEELING, DFL, DION,
DOLPHINOFF, ELEMARB, FERROALL, FLFL, FLORENCE, FORTUNEF, GALLANTT, GALLISPAT, GLOBOFFS,
GOODRICKE, GRANDFONRY, GRPLTD, GUJBOROS, HALDER, HARITASEAT, HBSTOCK, HEROMOTOCO, HINDWRS,
IDEA, INDOBORAX, INDOSOLAR, INDOTHAI, INOXLEISUR, IOLCP, IVC, JAMESWARREN, JDORGOCHEM, JPTSEC,
KANCHI, KCP, KLGCAP, KOTHARIFIN, LAKSELEC, LLORF, LUMAXIND, MADHUDIN, MAITHANALL, MAJESAUT,
MANGIND, MAVENSBIO, MAXINDIA, MCLEODRUSS, MEDINOV, MFSL, MINDAFIN, MODI, MODINATUR,
MONNETIN, MONNETPRO, MRO-TEK, MUKANDENGG, MUKANDLTD, NAVNETEDUL, NITINFIRE, OSCARGLO,
OSWALEA, OUDHSUG, PINEANIM, PNTKYOR, POLARIS, POLYLINK, POLYMED, PRECISIO, PRECISION, PREMCAP,
PTL, RAAJMEDI, RADHEY, RAMRAT, REDEXPR, ROLCOEN, SAGL, SANCTRN, SAVFI, SCC, SCHNEIDER, SETCO,
SHAKTIGAS, SHARP, SHERVANI, SHYMINV, SKIPPER, SOFCOM, SONAL, SONATSOFTW, SPHEREGSL, SRF,
STERTOOLS, SUBROS, SUDTIND-B, SUNDARAM, SURYAKR, SURYALA, TAMJAIM, TASTYBIT, TECHNOFAB,
TRIMURTHI, ULTRAMAR, UPERGANGES, USHAMART, VADILALIND, VADILENT, VEGETABLE, VESUVIUS,
VGPRFOO, VIKASECO, VIRATCRA, VKAL, WESTLEIRES, YASHMGM, YASHRAJC, ZENTEC, ZKHANDEN, ZSHERAPR,
ZSPEEDCO.
Corporate Action / Result Calendar
Bulk Deal
Security in Ban
Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price
1 5/8/2016 531508 EVEREADY GOLDMAN SACHS INDIA FUND LTD S 1627104 240.05
2 5/8/2016 523236 SHRENUJ BRIDGE INDIA FUND S 1350000 2.64
3 5/8/2016 531508 EVEREADY NOMURA INDIA INVESTMENT FUND MOTHER F B 900000 240.00
4 5/8/2016 532310 SHREERAMA RAJYOG SHARE AND STOK BROKERS LTD S 673000 8.55
5 5/8/2016 538365 ADHUNIKIND GYANESHWAR CONSULTANTS LIMITED LIABILIT S 550000 136.00
6 5/8/2016 538365 ADHUNIKIND AVANTIKA ADVISORY SERVICES LLP B 550000 136.00
7 5/8/2016 533208 EMAMIPAP PLACID LIMITED S 400000 71.53
8 5/8/2016 506615 SUNASIAN ROYAL REALTORS S 264290 4.63
9 5/8/2016 522209 YOGISUNG RT SUPER TECHNOLOGIES PRIVATE LIMITED S 210060 2.35
10 5/8/2016 523844 INVICTA RT SUPER TECHNOLOGIES PRIVATE LIMITED S 145342 3.75
JINDALSTEL

3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Sr. Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Kapil Shah Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
08th Aug 2016
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kunal Parmar
Digitally signed by Kunal Parmar
DN: cn=Kunal Parmar, o=Choice Equity Broking
Pvt Ltd., ou=Research Dept,
email=kunal.parmar@choiceindia.com, c=IN
Date: 2016.08.08 08:29:48 +05'30'